• Founder and Chairman of Efung Capital

• Tsinghua PBCSF MAB

• CKGSB EMBA

• DBA Candidate of Paris School of Business (PSB)

• Honorary Chairman of HKBMIA

• Sino-PhIRDA Investment Committee Sponsor

• Bayhelix Group Member

Dedicated to healthcare industry investment for 20 years, Mr. Zhu He has played a leading role in investing serval promising pharmaceutical projects, and fostered the development of healthcare industry in China. Thus Mr. Zhu was nominated for “China Finance Person of The Year 2019”, “Top 10 Healthcare Investor 2019”and “2020 Best Investor in Healthcare Industry”.

Mr. Zhu has displayed his excellent expertise in healthcare investment, his classical investment portfolios include: Mindray, Chipscreen Bioscience, Frontier Biotech, Ascentage Pharma, Lifotronic Technology, Harbour BioMed, OBiO Technology, Asieris Pharma, Biostar Technologies, 3D Medicines, Centrexion and Apexigen et al.